Enabling Personalized Therapy with PBPK Modeling for Pediatric Epilepsy
GRIN Therapeutics, Inc., an affiliate of Neurvati Neurosciences, focuses on the research and development of…
Danielle Pillsbury2025 年 4 月 16 日
Write Quicker PBPK Reports with the Simcyp Report Assistant
2025 年 4 月 11 日 Writing a report for PBPK models can be an onerous process, especially…
Danielle Pillsbury2025 年 4 月 11 日
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
RADNOR, PA — April 1st, 2025 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2025 年 4 月 1 日
PBBM Educational Webinar Series (Part 1): The Basics of Drug Absorption in Drug Development – Why is Drug Absorption Essential? [Japanese Webinar]
Part 2 on July 17th : What is the Drug Absorption Model? Part 3 in…
Danielle Pillsbury2025 年 2 月 27 日
Simcyp Version 24: Advancing PBPK capabilities and translating new science and technology into regulatory-accepted predictive modeling
With the release of Version 24, the Simcyp Simulator introduces cutting-edge enhancements that further elevate…
Danielle Pillsbury2025 年 2 月 7 日
Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards
Predicting metabolic drug–drug interactions (DDIs) via cytochrome P450 enzymes (CYP) is essential in drug development,…
Danielle Pillsbury2024 年 12 月 12 日
Real-world application of physiologically based pharmacokinetic models in drug discovery
The utility of physiologically based pharmacokinetic (PBPK) models in support of drug development has been…
Danielle Pillsbury2024 年 11 月 22 日
Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women
The article "Recent Applications of Pharmacometrics and Systems Pharmacology Approaches to Improve and Optimize Drug…
Danielle Pillsbury2024 年 11 月 18 日
